ImmunityBio (IBRX) Other Non-Current Assets (2014 - 2026)

ImmunityBio (IBRX) has 13 years of Other Non-Current Assets data on file, last reported at $378000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $378000.0 in Q1 2026; TTM through Mar 2026 was $378000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $4.5 million, up 1.82% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $378000.0, down from $4.5 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for IBRX reached as high as $6.5 million in Q1 2022 and fell as low as $378000.0 in Q1 2025.
• Historically, Other Non-Current Assets has averaged $3.6 million across 5 years, with a median of $3.8 million in 2023.
• Across the five-year window, Other Non-Current Assets jumped 3518.44% in 2022 and tumbled 86.15% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $4.9 million in 2022, then plunged by 40.74% to $2.9 million in 2023, then surged by 54.48% to $4.4 million in 2024, then gained by 1.82% to $4.5 million in 2025, then sank by 91.66% to $378000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $378000.0 in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.